prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |28 |29 |30 |31 |review
Short-acting analogs: Onset - 15 min. Peak - 1-2 hrs. Duration: 4-6 hrs.
Reg.: Onset - 30 - 60 min. Peak:2-4 hrs. Duration: 6-8 hrs.
Glargine: Onset - 2-4 hrs.  Peak: flat.  Duration: 24 hrs
R
 
Insulin analogues offer a much more physiologic insulin profile than do older insulin preparations and allow development of a treatment strategy that gives patients much more dietary freedom using a basal-bolus insulin with carbohydrate counting.
 
CSII provides the ultimate in physiologic insulin delivery and will soon be linked to a continuous glucose monitoring technology that brings insulin treatment closer to the dream of a closed loop system or “artificial pancreas”.